Navigation Links
How to Achieve Alignment and Optimal Clinical Trial Supply Forecasting With a Single Source of Truth, Upcoming Webinar Hosted by Xtalks
Date:11/2/2019

A clinical trial usually involves many different parties, who are not always used to communicating with each other: study managers, principal investigators, supply chain managers, manufacturers, IRT, CRAs and so on. Lack of communication can cause misunderstandings if a party is not informed of the latest data, potentially leading to patient risk.

By having a single source of truth, each collaborator can transparently access the latest clinical forecasts as well as up-to-date data including enrollment and dropout rate, titrations probabilities, future productions, etc. The reliability of this information is a must as it plays a fundamental role in the clinical supply strategy, as well as planning including distribution, packaging, manufacturing and sampling.

Join Head of Solutions Adoption, Life Sciences at N-SIDE, Amaury Jeandrain and N-SIDE Consultant, Pauline Deplasse in a live session on Tuesday, November 19, 2019 at 10am EST (3pm GMT/UK) to learn about the benefits of having a single source of truth when managing clinical operations.

If everyone agrees on this single source of truth, the resulting forecasts can legitimately be used across the organization for resource planning activities, decision-making, vendor management, etc. through strategic visualization dashboards.

When changes occur, such as faster enrollment, batch losses, shipping delays, new countries in the trial, real-time monitoring and updating clinical trial supply forecasts, using real-time data allows the single source of truth to stay current. This enables everyone across the organization to adapt their planning in order to mitigate the unexpected risk, ensuring patients will receive their medication on time while minimizing the costs.

The featured speakers will discuss how to get clinical trial stakeholders on the same page, using a single source of truth for patient behavior, demand forecast, production/distribution plans and inventory management.

For more information or to register for this event, visit How to Achieve Alignment and Optimal Clinical Trial Supply Forecasting With a Single Source of Truth.

ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks, visit http://xtalks.com.
For information about hosting a webinar, visit http://xtalks.com/why-host-a-webinar/.

Contact:
Candice Tang
Tel: +1 (416) 977-6555 ext 400
Email: ctang@xtalks.com

Read the full story at https://www.prweb.com/releases/how_to_achieve_alignment_and_optimal_clinical_trial_supply_forecasting_with_a_single_source_of_truth_upcoming_webinar_hosted_by_xtalks/prweb16686106.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related biology technology :

1. Dr. Ritchie Shoemaker Pleased to Announce Second Physician Achieves Shoemaker Protocol Certification for Treating Chronic Inflammatory Response Syndrome
2. Heptares Achieves All Research Milestones and Receives Milestone Payment From GPCR Drug Discovery Agreement With Takeda
3. Pioneering Researchers Recognized for Scientific Achievements in Gene and Cell Therapy
4. Cellular Biomedicine Group Achieves 50% Enrollment Milestone in Phase I Clinical Trial for Knee Osteoarthritis
5. Ohr Pharmaceutical Achieves 50% Enrollment Milestone in Squalamine Eye Drop Phase II Clinical Trial
6. AMS Co-Founder John Hauser Receives Lifetime Achievement Award
7. PTC Therapeutics Announces Achievement Of Major Milestone In SMA Collaboration
8. Pathogenica Achieves CE Marking for HAI BioDetection Kit
9. Medflow EHR Achieves ONC-ACB Certification by Drummond Group
10. Circassias Short-Course House Dust Mite Allergy Treatment Achieves Significant Long-Term Symptom Reduction
11. Biotech Firms Receive Orphan Drug Designations, Release Clinical Data, Achieve Goals, Enter Acquisitions & Forecast Revenues - Research Report on Aegerion, Oncolytics, Merrimack, Sangamo, and PDL
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/2/2019)... ... October 31, 2019 , ... Join Patrick Raber, PhD, Manager, ... webinar on Friday, November 15, 2019 at 1pm EST to learn about ... profiling T-cell receptors (TCRs) and B-cell receptors (BCRs), has been widely utilized to ...
(Date:10/30/2019)... (PRWEB) , ... October 30, 2019 , ... While using ... researchers and students at South Dakota School of Mines & Technology are ... while leaving healthy cells alive. , If successful, the technique would prove to ...
(Date:10/29/2019)... ... , ... CaroGen Corporation , a biotechnology company, today announced three distinguished ... R Wands, MD, of Brown University , Dr. Steve Projan, PhD, FAAM, ... PhD, of Wayne State University, formerly a professor at Yale University School of Medicine ...
(Date:10/29/2019)... NEWTON, Mass. (PRWEB) , ... October 29, 2019 ... ... the spectral signature of the skin*. Using Silios CMS-C multispectral imagers , ... This new approach can replace identification based on retinal imaging, face recognition, fingerprints ...
Breaking Biology Technology:
(Date:10/27/2019)... ... , ... Since 2010, The HOTH has served over 200,000 businesses with awesome ... clients, they’ve earned a place on the highly-competitive and desirable Inc. 5,000 List of ... and accolades along the way. , Now, The HOTH is ready to ...
(Date:10/26/2019)... ... October 23, 2019 , ... ... nanotube surface that demonstrated the FDA requirements for nanotechnology. , “We are ... This nanotechnology plays an important role in achieving Nanovis’ goal to reduce the ...
(Date:10/26/2019)... , ... October 24, 2019 , ... THE PRINCESS VEST, ... been the standard choice for female providers, they were the only choice. Women in ... breasts, or a loose garment that can allow harmful radiation to penetrate the sides ...
Breaking Biology News(10 mins):